Joint Formulary & PAD

Patiromer - Hyperkalaemia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Patiromer
Indication :
Hyperkalaemia
Group Name :
Keywords :
potassium, cation exchange
Brand Names Include :
Veltassa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Patiromer is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hyperkalaemia.

Committee Recommendations (1)

The Surrey & North West Sussex Area Prescribing Committee recommends Patiromer as a treatment option for the treatment of Hyperkalaemia in adults in line with NICE TA623 in emergency care for acute life threatening hyperkalaemia or for patients with persistent hyperkalaemia (in line with NICE thresholds).

Patiromer will be considered RED on the traffic light system in all cases.

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.